Renal involvement in aa amyloidosis: Clinical outcomes and survival

Kidney and Blood Pressure Research

Volumn 37, Issue 1, 2013, Pages 33-42

  Yilmaz, Murvet ^a,e   Unsal, Abdulkadir ^b   Sokmen, Mehmet ^c   Kaptanogullari, Ozlem Harmankaya ^a   Alkim, Canan ^b   Kabukcuoglu, Fevziye ^b   Ozagari, Aysim ^b   Bor, Emire ^d  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c UMRANIYE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d Bioistatistic   (Turkey)

^e Kartaltepe Mahallesi Incirli Caddesi   (Turkey)

Author keywords

AA amyloidosis; Chronic kidney disease; Proteinuria; Survival

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; CHOLESTEROL; CREATININE; TRIACYLGLYCEROL; UREA; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; CACHEXIA; CREATININE BLOOD LEVEL; DIALYSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; HUMAN; HYPERKALEMIA; INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; TUBERCULOSIS; AA AMYLOIDOSIS; ADOLESCENT; AGED; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; END STAGE RENAL DISEASE; HUMAN TISSUE; KIDNEY AMYLOIDOSIS; MEDICAL RECORD REVIEW; MORTALITY; RENAL REPLACEMENT THERAPY; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84875667494     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000343398     Document Type: Article

References (28)

1. Potysova Z, Merta M, Tesar V, Jancova E, Honsova E, Rysava R: Renal AA amyloidosis: survey of epidemiologic and laboratory data from one nephrology centre. Int Urol Nephrol 2009;41:941-945.
2. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM: Presentation, survival and prognostic markers in AA amyloidosis. QJM 2000;93:535-542.
3. Dember L: Amyloidosis associated Kidney Disease. J Am Soc Nephrol 2006;17:3458-3471.
4. Gertz MA, Kyle RA: Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 1994;24:124-138.
5. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G: Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005;1753:11-22.
6. Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Düsünsel R, Evrenkaya R, Akoglu E: A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 2002;17:2003-2005.
7. Tiitinen S, Myllykangas R, Helin H, Kaarela K: Modern trends in the diagnosis of secondary amyloidosis. Scand J Rheumatol Suppl 1987;67:30-31.
8. Yilmaz M, Unsal A, Sokmen M, Harmankaya O, Alkim C, Kabukcuoglu F, Ozagari A: Duodenal biopsy for diagnosis of renal involvement in amyloidosis. Clin Nephrol 2012;77:114-118.
9. Triger DR, Joekes AM: Renal amyloidosis-a fourteen-year follow-up. Q J Med 1973;42:15-40.
10. Browning MJ, Banks RA, Tribe CR, Hollingworth P, Kingswood C, Mackenzie JC, Bacon PA: Ten years' experience of an amyloid clinic-a clinicopathological survey. Q J Med 1985;54:213-227.
11. Gertz MA, Kyle RA: Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991;70:246-256
12. Schnitzer TJ, Ansell BM: Amyloidosis in juvenile chronic polyarthritis. Arthritis Rheum 1977;20:245-252.
13. David J, Vouyiouka O, Ansell BM, Hall A, Woo P: Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993;11:85-90.
14. Berglund K, Keller C, Thysell H: Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease. Ann Rheum Dis 1987;46:757-762.
15. Ahlmen M, Ahlmen J, Svalander C, Bucht H: Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 1987;6:27-38.
16. Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K: Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003;21:343-346.
17. Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M, Immunopathology Group of the Italian Society of Nephrology: Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Nephrol Dial Transplant 2008;23:941-951.
18. Sasatomi Y, Kiyoshi Y, Uesugi N, Hisano S, Takebayashi S: Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis. Nephron 2001;87:42-49.
19. Bohle A, Wehrmann M, Eissele R, von Gise H, Mackensen-Haen S, Müller C: The long-term prognosis of AA and AL renal amyloidosis and the pathogenesis of chronic renal failure in renal amyloidosis. Pathol Res Pract 1993;189:316-331.
20. Fernandez-Nebro A, Olive A, Castro MC, Varela AH, Riera E, Irigoyen MV, Garcia de Yebenes MJ, Garcia-Vicuña R: Long-term TNF-alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. Am J Med 2010;123:454-461.
21. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN: Natural history and outcome in systemic AA amyloidosis: N Engl J Med 2007;356:2361-2371.
22. Falck HM, Maury CP, Teppo AM, Wegelius O: Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J (Clin Res Ed) 1983;286:1391-1393.
23. Moroni G, Banfi G, Montoli A, Bucci A, Bertani T, Ravelli M, Pozzi C, Leonelli M, Lupo A, Volpi A, et al: Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. Clin Nephrol 1992;38:81-85.
24. Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991;6:5-35.
25. Ylinen K, Grönhagen-Riska C, Honkanen E, Ekstrand A, Metsärinne K, Kuhlbäck B: Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 1992;7:908-912.
26. Port FK, Nissenson AR: Outcome of end-stage renal disease in patients with rare causes of renal failure. II. Renal or systemic neoplasms. Q J Med 1989;73:1161-1165.
27. Martinez-Vea A, Garcia C, Carreras M, Revert L, Oliver JA: End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Am J Nephrol 1990;10:283-289.
28. Janssen S, Van Rijswijk MH, Meijer S, Ruinen L, Van der Hem GK: Systemic amyloidosis: a clinical survey of cases. Neth J Med 1986;29:376-385.